Xiangwei Kong

Title: Innovations of Xiangwei Kong in Nanoparticle Technology.

Introduction

Xiangwei Kong is a notable inventor based in Guangdong, China. He has made significant contributions to the field of nanoparticle technology, particularly in relation to the Epstein-Barr virus (EBV). His work focuses on the development of self-assembled nanoparticles that have potential applications in medical research and treatment.

Latest Patents

Xiangwei Kong holds a patent for a self-assembled nanoparticle containing the gB protein of the EB virus. The patent describes a preparation method and the use of this nanoparticle. The self-assembled nanoparticle comprises a first polypeptide, which includes the gB protein and a first vector subunit, and a second polypeptide that contains a second vector subunit. The first vector subunit is I53-50A1, while the second vector subunit is I53-50B.4PT1. This innovative nanoparticle displays the gB protein of the EB virus on its surface for the first time. The particle size of the self-assembled nanoparticle is larger than that of the antigen gB, and it exhibits higher chemical stability and binding capacity with neutralizing antibodies compared to the antigen gB. He has 1 patent in total.

Career Highlights

Xiangwei Kong has worked at prestigious institutions, including Sun Yat-sen University and the Sun Yat-sen University Cancer Center. His research has contributed to advancements in understanding and potentially combating viral infections.

Collaborations

One of his notable collaborators is Cong Sun, with whom he has worked on various research projects.

Conclusion

Xiangwei Kong's innovative work in nanoparticle technology represents a significant advancement in the field of virology. His contributions may pave the way for new therapeutic approaches to combat viral infections.